The UCLA Fielding School of Public Health and the UCLA Center for Chinese Studies present The Novel Coronavirus: What Do We Know and What's Next?, a symposium and reception. The novel coronavirus (2019-nCoV) was first reported in Wuhan, China in December 2019. On January 30, 2020, the WHO declared the outbreak a public health emergency of
The World Health Organization will host a Global research and innovation forum 11-12 February in Geneva to mobilize international action in response to the novel coronavirus (2019-nCoV) emergency. The event is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R), and brings together key players including leading scientists as well as
The U.S. Senate Committee on Homeland Security & Governemental Affairs will convene a Full Committee hearing on Feb.12 to examine protecting the United States from global pandemics. ROUNDTABLE: Are We Prepared? Protecting the U.S. from Global Pandemics will February 12, 2020 09:30 AM Location: SD-G50, Dirksen Senate Office Building The meeting will air on CSPAN. See
CEPI has opened a call for proposals to rapidly develop and manufacture a proven vaccine approach that can be used against 2019-nCoV. The call is open for two weeks until mid-February. Applications are open worldwide to all types of non-profit research organisations, for-profit companies, international organisations and foundations, joint R&D ventures, government research organisations, and
PHEP Recipient Monthly Conference Call Scheduled for February 19 CDC’s next monthly conference call with PHEP recipients will be held from 3 p.m. to 4 p.m. EDT on Wednesday, February 19. Participant information is provided below. Conference Call Information Bridge Line: (888) 566-1873 Participant Code: 3358383 The Public Health Emergency Preparedness (PHEP) cooperative
Target Audience: Health care providers (including primary care physicians & nursing professionals) Key Note Speakers: Dr. Gerald Evans Chair of the Division of Infectious Diseases, Professor of Medicine, Queens University; Attending Staff, Kingston Health Sciences Centre Dr. Piotr Oglaza Medical Officer of Health & CEO, Hastings Prince Edward Public Health Yvonne DeWit, Epidemiologist, Hastings Prince
The capability to provide unburdened chem-bio protection will maximize time on target for the warfighter and the stability operator, provide operational flexibility, extend mission duration, and enable military operations in austere environments regardless of the threat. PPB will consist of lightweight materials that protect the warfighter from exposure to any CB threat while simultaneously providing
The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. A number of countries, including the U.S., are actively screening incoming travelers from Wuhan. Starting January 21, 2020, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national
A U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity will be held Feb 25-26, 2020 at the NIAID Conference Center in Rockville, Md. This meeting, sponsored by the NIH Chemical Countermeasures Research Program (CCRP) and organized in collaboration with the National Eye Institute (HHS/NIH/NEI) and
